rs2435351

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020975.6(RET):​c.337+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.25 in 1,583,280 control chromosomes in the GnomAD database, including 52,243 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3868 hom., cov: 31)
Exomes 𝑓: 0.25 ( 48375 hom. )

Consequence

RET
NM_020975.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:19

Conservation

PhyloP100: 1.12

Publications

15 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-43100731-G-A is Benign according to our data. Variant chr10-43100731-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 95996.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.279 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.337+9G>A
intron
N/ANP_066124.1P07949-1
RET
NM_001406743.1
c.337+9G>A
intron
N/ANP_001393672.1P07949-1
RET
NM_001406744.1
c.337+9G>A
intron
N/ANP_001393673.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.337+9G>A
intron
N/AENSP00000347942.3P07949-1
RET
ENST00000340058.6
TSL:1
c.337+9G>A
intron
N/AENSP00000344798.4P07949-2
RET
ENST00000713926.1
c.337+9G>A
intron
N/AENSP00000519223.1A0AAQ5BH28

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31729
AN:
151540
Hom.:
3864
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0949
Gnomad AMI
AF:
0.350
Gnomad AMR
AF:
0.260
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.100
Gnomad SAS
AF:
0.291
Gnomad FIN
AF:
0.258
Gnomad MID
AF:
0.261
Gnomad NFE
AF:
0.259
Gnomad OTH
AF:
0.212
GnomAD2 exomes
AF:
0.257
AC:
50491
AN:
196552
AF XY:
0.258
show subpopulations
Gnomad AFR exome
AF:
0.0954
Gnomad AMR exome
AF:
0.356
Gnomad ASJ exome
AF:
0.241
Gnomad EAS exome
AF:
0.102
Gnomad FIN exome
AF:
0.258
Gnomad NFE exome
AF:
0.259
Gnomad OTH exome
AF:
0.267
GnomAD4 exome
AF:
0.255
AC:
364788
AN:
1431622
Hom.:
48375
Cov.:
51
AF XY:
0.256
AC XY:
181424
AN XY:
709260
show subpopulations
African (AFR)
AF:
0.0896
AC:
2961
AN:
33062
American (AMR)
AF:
0.342
AC:
13831
AN:
40452
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
6283
AN:
25512
East Asian (EAS)
AF:
0.0886
AC:
3417
AN:
38576
South Asian (SAS)
AF:
0.302
AC:
24967
AN:
82536
European-Finnish (FIN)
AF:
0.255
AC:
12687
AN:
49806
Middle Eastern (MID)
AF:
0.276
AC:
1314
AN:
4766
European-Non Finnish (NFE)
AF:
0.260
AC:
285060
AN:
1097762
Other (OTH)
AF:
0.241
AC:
14268
AN:
59150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
14805
29610
44416
59221
74026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9594
19188
28782
38376
47970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.209
AC:
31738
AN:
151658
Hom.:
3868
Cov.:
31
AF XY:
0.212
AC XY:
15735
AN XY:
74094
show subpopulations
African (AFR)
AF:
0.0947
AC:
3922
AN:
41422
American (AMR)
AF:
0.260
AC:
3962
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
853
AN:
3470
East Asian (EAS)
AF:
0.101
AC:
519
AN:
5164
South Asian (SAS)
AF:
0.292
AC:
1402
AN:
4808
European-Finnish (FIN)
AF:
0.258
AC:
2687
AN:
10412
Middle Eastern (MID)
AF:
0.257
AC:
75
AN:
292
European-Non Finnish (NFE)
AF:
0.259
AC:
17561
AN:
67862
Other (OTH)
AF:
0.210
AC:
440
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1169
2338
3507
4676
5845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.234
Hom.:
2329
Bravo
AF:
0.207
Asia WGS
AF:
0.182
AC:
631
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
Pheochromocytoma (2)
-
-
1
Hirschsprung disease, susceptibility to, 1 (1)
-
-
1
Multiple endocrine neoplasia (1)
-
-
1
Multiple endocrine neoplasia type 2A (1)
-
-
1
Multiple endocrine neoplasia type 2B (1)
-
-
1
Multiple endocrine neoplasia, type 2 (1)
-
-
1
Renal hypodysplasia/aplasia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
11
DANN
Benign
0.80
PhyloP100
1.1
PromoterAI
0.053
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2435351; hg19: chr10-43596179; COSMIC: COSV60687075; COSMIC: COSV60687075; API